Twenty of 33 committee members vote to keep rosiglitazone on the market, with most favoring stronger labeling and restrictions on prescribing. read more
Two advisory panels recommended that FDA allow the trial of GlaxoSmithKline's Avandia (rosiglitazone) to continue but questioned its design, providing important hints for drug companies planning post-marketing safety trials in the future. read more
The Senate Finance Committee's top health care staffer for health reform, Elizabeth Fowler, is moving to HHS to help with the implementation of the Affordable Care Act. read more
Germany's Ministry of Research aims to encourage industry ties with academia to support pursuit of personalized medicines. read more
Belgium promises to make progress on a single EU patent, but its plans are opposed by Italy and Spain. read more
A federal judge says the facts show "the strong possibility" that FTC tried to broker a deal between Watson and Apotex requiring Watson to give up its marketing exclusivity for generic Provigil. read more
FDA's David Dorsey and CMS' Barry Straube are tasked with overseeing the data-sharing memorandum of understanding between the two agencies. read more
Charles River says the CRO's major pharma clients support the deal. read more"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here
